Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee OsteoarthritisContributed by: Business WireLogoImagesHealth Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee OsteoarthritisTagsResearchFitness & NutritionClinical TrialsBiotechnologyManaged CareGeneral HealthPharmaceuticalHealthScienceOther ScienceHealth Canada, Phase 2a, INFLAM MOTION, Clinical Trial